Geode Capital Management LLC Purchases 66,712 Shares of Vigil Neuroscience, Inc. (NASDAQ:VIGL)
Geode Capital Management LLC lifted its position in Vigil Neuroscience, Inc. (NASDAQ:VIGL – Free Report) by 41.9% during the 3rd quarter, HoldingsChannel reports. The firm owned 226,083 shares of the ...
Vigil Neuroscience Highlights 2024 Corporate Achievements and Upcoming 2025 Milestones
On track to report data from Phase 1 clinical trial evaluating VG-3927 for the treatment of Alzheimer’s disease in 1Q 2025 –– Final analysis ...
Pharmaceutical Technology5d
Iluzanebart by Vigil Neuroscience for Unspecified Neurologic Disorders: Likelihood of Approval
Iluzanebart is under clinical development by Vigil Neuroscience and currently in Phase I for Unspecified Neurologic Disorders.
Firefly Neuroscience Closes on Financing of up to $12.4 Million
Firefly Neuroscience, Inc. (“Firefly,” “we,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain health outcomes for patients ...
Alto Neuroscience, Inc. (NYSE:ANRO) Stake Raised by Geode Capital Management LLC
Geode Capital Management LLC grew its holdings in shares of Alto Neuroscience, Inc. (NYSE:ANRO – Free Report) by 148.7% in ...